Anouk Verwoerd

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis

Adriane D.M. Vorselaars, Anouk Verwoerd, Coline H.M. van Moorsel et al. · European Respiratory Journal · 2013 · 142 citations · Full text

Disease Progression, Immunodeficiencies, Prognosis +21

Reversal of Sepsis‐Like Features of Neutrophils by Interleukin‐1 Blockade in Patients With Systemic‐Onset Juvenile Idiopathic Arthritis

Nienke M. ter Haar, Tamar Tak, Michal Mokrý et al. · Arthritis & Rheumatology · 2018 · 42 citations

Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis

Anouk Verwoerd, Daniëlle Hijdra, Adriane D.M. Vorselaars et al. · Clinical & Experimental Immunology · 2016 · 25 citations · Full text

Recombinant Interleukin‐1 Receptor Antagonist Is an Effective <scp>First‐Line</scp> Treatment Strategy in <scp>New‐Onset</scp> Systemic Juvenile Idiopathic Arthritis, Irrespective of <scp>HLA‐DRB1</scp> Background and <scp><i>IL1RN</i></scp> Variants

Remco Erkens, Jorg J. A. Calis, Anouk Verwoerd et al. · Arthritis & Rheumatology · 2023 · 24 citations · Full text

Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritis

Anouk Verwoerd, Wineke Armbrust, Katherine Cowan et al. · Pediatric Rheumatology · 2021 · 18 citations · Full text